Merck Co Stock Shares Owned By Insiders
MRCK34 Stock | BRL 77.28 2.55 3.41% |
Merck Co fundamentals help investors to digest information that contributes to Merck's financial success or failures. It also enables traders to predict the movement of Merck Stock. The fundamental analysis module provides a way to measure Merck's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Merck stock.
Merck |
Merck Co Company Shares Owned By Insiders Analysis
Merck's Shares Owned by Insiders show the percentage of outstanding shares owned by insiders (such as principal officers or members of the board of directors) or private individuals and entities with over 5% of the total shares outstanding. Company executives or private individuals with access to insider information share information about a firm's operations that is not available to the general public.
More About Shares Owned By Insiders | All Equity Analysis
Insiders Shares | = | Executives Shares | + | Employees |
Although the research on effects of insider trading on prices and volatility is still relatively inconclusive, and investors are advised to pay close attention to the distribution of equities among company's stakeholders to avoid many problems associated with the disclosure of price-sensitive information.
Competition |
Based on the latest financial disclosure, 0.0% of Merck Co are shares owned by insiders. This is 100.0% lower than that of the Healthcare sector and 100.0% lower than that of the Drug Manufacturers - Major industry. The shares owned by insiders for all Brazil stocks is 100.0% higher than that of the company.
Did you try this?
Run USA ETFs Now
USA ETFsFind actively traded Exchange Traded Funds (ETF) in USA |
All Next | Launch Module |
Merck Fundamentals
Return On Equity | 0.35 | |||
Return On Asset | 0.13 | |||
Profit Margin | 0.24 % | |||
Operating Margin | 0.38 % | |||
Current Valuation | 1.6 T | |||
Shares Outstanding | 20.28 B | |||
Price To Earning | 96.57 X | |||
Price To Book | 6.31 X | |||
Price To Sales | 25.29 X | |||
Revenue | 59.28 B | |||
Gross Profit | 44.14 B | |||
EBITDA | 18.28 B | |||
Net Income | 14.52 B | |||
Cash And Equivalents | 8.8 B | |||
Cash Per Share | 3.42 X | |||
Total Debt | 30.69 B | |||
Debt To Equity | 97.40 % | |||
Current Ratio | 1.37 X | |||
Book Value Per Share | 2.19 X | |||
Cash Flow From Operations | 14.11 B | |||
Earnings Per Share | 3.78 X | |||
Price To Earnings To Growth | 1.35 X | |||
Number Of Employees | 44 | |||
Beta | 0.37 | |||
Market Capitalization | 1.46 T | |||
Total Asset | 105.69 B | |||
Z Score | 28.2 | |||
Annual Yield | 0.03 % | |||
Net Asset | 105.69 B | |||
Last Dividend Paid | 2.76 |
About Merck Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Merck Co's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Merck using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Merck Co based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Merck Stock
Merck financial ratios help investors to determine whether Merck Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Merck with respect to the benefits of owning Merck security.